BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  CareDx Reports Fourth Quarter and Full Year 2021 Results

  CareDx, Inc. reported financial results for the fourth quarter and full year ended December 31, 2021.

  February 24, 2022

   · 

  14 min read
• Business

  Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates

  Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported fourth quarter and full year 2021 financial results and corporate updates.

  February 24, 2022

   · 

  15 min read
• Business

  Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

  Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021.

  February 24, 2022

   · 

  30 min read
• Genetown

  Pulmatrix, Inc. Announces 1-for-20 Reverse Stock Split

  Pulmatrix, Inc. announced a 1-for-20 reverse split of its common stock, to be effective as of 4:05 p.m. Eastern Time on February 28, 2022.

  February 24, 2022

   · 

  6 min read
• Business

  Eiger BioPharmaceuticals to Host Conference Call for Fourth Quarter & Full Year 2021 Financial Results and Business Update on Thursday, March 10

  Eiger BioPharmaceuticals, Inc. announced that it will host a conference call on Thursday, March 10, 2022 at 4:30 PM ET to discuss its fourth quarter and full year 2021 financial results and provide a business update.

  February 24, 2022

   · 

  1 min read
• Business

  Natera Reports Fourth Quarter and Full Year 2021 Financial Results

  Natera, Inc., a global leader in cell-free DNA testing, reported financial results for the fourth quarter and year ended December 31, 2021 and provided an update on recent business progress and financial outlook.

  February 24, 2022

   · 

  14 min read
• Business

  Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021

  Invitae, a leading medical genetics company, announced financial and operating results for the fourth quarter and year ended December 31, 2021.

  February 24, 2022

   · 

  19 min read
• Business

  Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021

  Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, announced financial results for the fourth quarter and full year ended December 31, 2021, and provided its financial outlook for 2022.

  February 24, 2022

   · 

  19 min read
• Business

  Personalis Reports Fourth Quarter and Full Year 2021 Financial Results

  Personalis, Inc., a leader in advanced genomics for precision oncology, reported financial results for the fourth quarter and full year ended December 31, 2021.

  February 24, 2022

   · 

  10 min read
• BioForest

  NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd Annual Cowen Health Care Conference.

  February 24, 2022

   · 

  1 min read